Chicago, IL—Real-world patients with mitral regurgitation (MR) not meeting the COAPT eligibility criteria who ultimately underwent clip-based transcatheter mitral valve repair fared just as well as ...
NEW YORK, NY—More postmarket registry data confirm the safety and efficacy of mitral transcatheter edge-to-edge repair (M-TEER) with MitraClip (Abbott) in patients with secondary mitral regurgitation ...
COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF
SAN DIEGO, CA (UPDATED)—It’s a shocking success for the MitraClip after years of gloomy predictions, sluggish trial enrollment, and—most of all—the negative MITRA-FR trial results last month. Today, ...
Edge-to-edge transcatheter mitral valve repair with the MitraClip (Abbott) in heart failure patients with secondary mitral regurgitation (MR) lowers the risk of death or heart failure-related ...
One-year mortality rates for patients with secondary mitral regurgitation (MR) treated with the next-generation MitraClip NTR and XTR systems (Abbott) as part of the real-world, global EXPAND registry ...
NEW ORLEANS, LA—A detailed look at the echocardiographic results from the COAPT trial has failed to pinpoint any baseline echocardiographic factors that could help valve teams decide which patients ...
SAN DIEGO, CA (UPDATED)—I felt a pang of sympathy for 26 of the 27 “late-breaking” studies presented this year at TCT. In the lead-up to the meeting, rumors were rampant that COAPT was “different” ...
ATHENS, Greece—Heart failure experts gathered here at the European Society of Cardiology 2019 Heart Failure (ESC HF) Congress saw several new COAPT analyses and seemed at least partly reassured that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results